MJ Business Attorneys

JUNE 29, 2018

Epidiolex is the first drug the FDA has approved that contains a substance derived from marijuana, and it is also the first drug approved by the FDA to be used to treat patients with Dravet syndrome. Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. In the recent case Hemp Industries Associations v.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

AUGUST 12, 2021

Drug Enforcement Administration’s (DEA) refusal to accommodate state and federal right to try laws. US DEA , No. RTT laws permit certain patients who have been diagnosed with life-threatening diseases or conditions access to investigational medications not yet approved for general use by the U.S. 21-70544 (9th Cir.),

DEA 105

DEA Medicine Food Patients 105

Americans for Safe Access

JUNE 6, 2019

In July 2017, four medical cannabis patients joined other advocates in filing a lawsuit against the federal government in the U.S. Drug Enforcement Administration (DEA) to reschedule cannabis, before filing suit. District Court for the Second District of New York. The plaintiffs in the case (originally Washington v.

DEA 230

DEA Patients Cannabis 230

Veriheal

JUNE 22, 2021

Sue Sisley was quoted telling media, “there are thousands of different cannabis varieties that all have unique chemical profiles and produce unique clinical effects, but we didn’t have access to that normal diversity.” The post DEA Increases Access to Cannabis for Research Purposes appeared first on Cannabis Central.

DEA 66

DEA Access Therapy Cannabinoids 66

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. The FDA refers to this program as the expanded access program on their website. A Push by Patients. Patients Are Not In This Alone.

Therapy 64

Therapy DEA Patients Clinical Trials 64

Americans for Safe Access

SEPTEMBER 25, 2024

What's Inside For September 2024: DEA Hearing Delay on Cannabis Rescheduling Patients caught in the middle of CA Hemp Product Ban ASA releases What’s in Your Cannabis? A Patient & Consumer Guide to Navigating Cannabis Safety. Learn More about ASA Member Benefits & Join Today!

DEA 147

DEA Programs Patients Safety 147

Americans for Safe Access

JULY 22, 2024

Healthcare Experts & Cannabis Stakeholders Clear the Smoke on Cannabis Scheduling: Join a Physician, Pharmacist, Researcher, Caregiver, Veteran, Patients, and Patient Advocates as They Bring the Rescheduling Debate to Life Washington, DC – Public comment closes today on the Department of Justice’s (DOJ) proposed rule to move cannabis (marijuana) (..)

Media 130

Media DEA Patients Marijuana 130

Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52

DEA Patients Therapy Access 52

Cannabis Law Report

FEBRUARY 24, 2023

DEA extends many telemedicine flexibilities adopted during the COVID-19 PHE with appropriate safeguards WASHINGTON – Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 (..)

DEA 52

DEA Therapy Access Patients 52

Canna Law Blog

MARCH 4, 2020

According to the FDA , “once the FDA approves a drug, healthcare providers generally may prescribe the drug for an unapproved use when they judge that it is medically appropriate for their patient.” That access would be available under the auspices of having a chronic, untreatable mood disorder.

Legalization 115

Legalization Therapy Chronic Pain DEA 115

WeedAdvisor

JUNE 1, 2019

The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis.

DEA 55

DEA Marijuana History Cannabis 55

Cannabis Law Report

OCTOBER 4, 2021

One of the known beneficial uses of psilocybin is as a palliative care tool for patients with advanced illness who suffer from anxiety and/or depression. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment.

Therapy 52

Therapy Patients Law Clinical Trials 52

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ?

DEA 51

DEA Clinical Trials THC Research and Development 51

Veriheal

APRIL 11, 2022

You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Medicine 105

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. Circuit), a pending petition for review of DEA’s August 2020 Interim Final Rule purportedly implementing the 2018 Farm Bill’s amendments to the CSA.

DEA 85

DEA Cultivation Hemp Advocacy 85

The Cannigma

MAY 16, 2025

The successes of cannabis businesses are now a part of the mainstream conversation and considered big business, while the rights and protections for medical cannabis patients have been sidelined. So while a cannabis business can join their local chamber of commerce, a patient in hospice can be denied access to medical cannabis.

Policy 93

Policy Access Advocacy Patients 93

Marijuana Lawyer Blog

JANUARY 12, 2019

As our Los Angeles marijuana patient attorneys can explain, the crux of the argument by plaintiffs of the claim, first filed in 2017, is that the designation ignores the merits of the drug for medicinal purposes. Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government.

DEA 40

DEA Patients Medicine Epilepsy 40

Cannabis Law Report

FEBRUARY 8, 2022

The law, which has some doctors saying they have stopped working with medical cannabis patients altogether, requires that patients obtain written “certifications” from doctors in order to access marijuana concentrates over a new daily limit. It is unknown how many doctors have decided to stop working with cannabis patients.

Patients 52

Patients Legislation Concentrates DEA 52

Veriheal

SEPTEMBER 13, 2022

With legalization, patients and consumers have more freedom in product choice, and many are turning to homegrown cannabis. It also may be more convenient to grow cannabis at home if a consumer lives in a rural area or in a state that only has a limited number of accessible dispensaries. Cultivation Costs for Homegrowers.

Cultivation 111

Cultivation Data DEA Dispensary 111

CannaMD

MAY 6, 2020

However, given rapidly evolving – and often complicated – laws surrounding medical marijuana, many patients feel overwhelmed. In practice, the chances of feds or the DEA sitting at the border waiting to catch someone – that’s just not happening. Visiting Qualifying Patients. Planning a vacation should be fun.

Hash 105

Hash Legalization Marijuana Concentrates 105

Veriheal

NOVEMBER 6, 2023

The Act aimed to provide patients access to smokable flower for 15 medical conditions. This progressive legislation, once implemented, means a brand new slew of patients will have access to cannabis medicine. In 2014, CBD with under 0.9% THC was legalized for qualifying conditions.

Legalization 119

Legalization Recreational THC CBD 119

SpeedWeed

APRIL 2, 2021

Hawaii House Approves Proposal For Cannabis Exemption From DEA. Hawaii lawmakers approved Wednesday a proposal that seeks an exemption from Drug Enforcement Administration (DEA) regulations, asking that the state is allowed to manage its medical cannabis program without federal involvement, reported Marijuana Moment.

DEA 52

DEA Programs Access Patients 52

Cannabis Law Report

NOVEMBER 2, 2022

Drug Enforcement Administration and the legal team representing terminally ill patients petitioning for access to psilocybin-assisted therapy. In late September, the DEA denied an official petition requesting that the agency look into rescheduling psilocybin from Schedule I to Schedule II.

Microdosing 52

Microdosing DEA Therapy Access 52

SpeedWeed

AUGUST 7, 2021

Democratic leaders in both chambers of Congress have come up with a new plan that would make it easier for scientists to access high-quality cannabis for research. . Researchers eventually filed multiple lawsuits demanding that the DEA license additional growers to provide a wide range of research-quality pot. View original article.

DEA 52

DEA Research and Development Legalization Strains 52

MedicalJane

JUNE 29, 2018

The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome. The Next Move Is On The DEA.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

JULY 1, 2021

Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries. We will also translate existing clinical research, making it more accessible to courts, lawmakers, federal agencies, and the public. Chloe Reichel: Can you describe the primary goals of POPLAR?

Law 81

Law Research and Development Therapy DEA 81

Cannabis Law Report

JULY 9, 2021

Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. Right to Try laws permit patients with serious or life-threatening diseases to access drugs that do not yet have government approval.

Law 81

Law Therapy Clinical Trials Research and Development 81

The Cannigma

MAY 6, 2021

If you have access to regulated cannabis that’s produced under acceptable standards, there’s no real reason to seek delta-8 products. The Drug Enforcement Administration (DEA) recently issued a clarification on the matter, stating that “All synthetically derived tetrahydrocannabinols remain schedule 1 controlled substances”.

THC 145

THC Cannabinoids Concentrates Hemp 145

SpeedWeed

JULY 13, 2021

Governor Polis is being faced with a lawsuit over House Bill 1317, a bill that negatively affected students who were meant to benefit from the law that allows cannabis use by medical patients in public schools. . There will also be expanded tracking on purchases, and limited purchases, even for medical cannabis patients. .

Law 52

Law Patients DEA Access 52

The Blunt Truth

DECEMBER 22, 2023

UNITED STATES ATTORNEYS Attorney General Merrick Garland and DEA Administrator Anne Milgram received a letter this week from several former United States Attorneys. GEORGIA As we reported last week, Georgia independent pharmacies received a letter from the DEA telling them to stop selling medical cannabis products.

DEA 52

DEA Retail Programs Hemp 52

Cannabis Law Report

MAY 2, 2019

One, the Veterans Equal Access Act, H.R. Earl Blumenauer, D-Oregon, would allow VA health providers to recommend medical marijuana to their veteran patients and fill out the necessary paperwork for them to enroll in state marijuana programs. 1647, sponsored by Rep. Full story at [link].

DEA 45

DEA Law Legislation Programs 45

Burns Levinson (Cannabusiness advisory)

OCTOBER 3, 2018

This marks the first time in history that the DEA has removed any type of cannabis from Schedule I, and clears the way for the sale of the first non-synthetic, cannabis-derived medicine to win federal approval. According to the DEA order, because the drug was recently approved by the FDA, it is now considered to have an accepted medical use.

CBD 40

CBD DEA Epilepsy Pharmaceutical 40

Veriheal

DECEMBER 1, 2020

An outdated study from the early 1990s conducted on chemotherapy patients that were children showed just like Delta-9 that Delta-8 helped prevent vomiting. The DEA is Already Interfering. Way to go, DEA, on jumping the gun showing your true colors.

THC 52

THC DEA Research and Development Cannabinoids 52

Veriheal

AUGUST 19, 2022

” Cannabis Research Should Be Based on Real, Accessible Products. Sue Sisley received for her study surrounding cannabis and PTSD was described as a “homogeneous green dust,” having no resemblance whatsoever to what is available for patients and consumers nationwide and in regulated markets. Yes, without a doubt.

Hemp 52

Hemp DEA Access Cultivation 52

SpeedWeed

AUGUST 16, 2021

Lepp was one of the industry’s greatest advocates, leaving his mark as one of many who suffered in prison as a result of trying to cultivate medical cannabis and help patients get access. At the time, it was considered to be one of the largest cannabis operations of its time, serving up to 1,000 medical cannabis patients.

DEA 52

DEA Patients Therapy Cannabis 52

Canna Care Docs

SEPTEMBER 26, 2019

Powered by Sail, we are on a mission to solve the issue of cannabis access for patients. We’re passionate about improving our patient’s quality of life and bringing cannabis into mainstream healthcare. Evaluate patient for verification of a qualifying condition. About Canna Care Docs…. Why Work for CannaCareDocs?

DEA 40

DEA History Therapy Patients 40

Cannabis Law Report

DECEMBER 15, 2021

The importation of the naturally derived psilocybin into California was completed after the Company’s supply partner Mycrodose Therapeutics was granted an import license from the United States Drug Enforcement Administration (DEA). “Having a supply partner that gives us access to the rapidly growing U.S.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52